 |
Biosketch
Dr. Cohen is Professor of Medicine with the National Jewish Medical and Research Center in Denver, Colorado. Dr. Cohen graduated from the George University School of Medicine and Health Science with an MD and has been in the profession for 31 years.
Affiliations
- Professor of Medicine
National Jewish Medical and Research Center
|
Activities involving Marc D. Cohen
1 result
 Released: Nov 15, 2007
 Expires: Nov 15, 2008
 Type: PDF
Currently, three tumor necrosis factor (TNF) antagonists are approved for the treatment of patients with rheumatoid arthritis (RA): infliximab, etanercept, and adalimumab. Whilst, overall, TNF antagonists are well tolerated and have demonstrated a favorable risk–benefit profile, there are lingering concerns over their long-term safety. For example, data from clinical trials...
|
- CME Credits/Hours: 2.00
- Cost: Free
-
System Requirements:
|
|